Barely Significant
← all excerpts

A randomized study to compare oral potassium binders in the treatment of acute hyperkalemia.

BMC Nephrol · 2023 · PMC10074796 · PMID 37016309

Europe PMCDOI
1
hedged sentence
0.0500
closest p · 1.0× alpha
0.0500
boldest claim

The sentences

a negative trendP < 0.05actually significant
Safety and tolerability will be assessed using a Kruskal-Wallis test to globally test for a negative trend across all 4 study treatments (two-sided P < 0.05) and, if significant, further testing will be done using a two-sided Fisher Exact test compare each potassium binder vs. the nonspecific laxative control.

also in 1,043 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.